LUMO - Lumos Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-3.4. This is a potential upside of $-7.74 (-178.34%) from yesterday's end of day stock price of $4.34.

Lumos Pharma's activity chart (see below) currently has 42 price targets and 45 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.33% with an average time for these price targets to be met of 322.91 days.

Most recent stock forecast was given by EDWARD WHITE from HCWAINWRIGHT on 08-Nov-2024. First documented stock forecast 10-May-2016.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 24-Oct-2024

$4.25

$-0.09 (-2.07%)

$4.25

1 years 3 months 15 days ago
(08-Nov-2024)

1/5 (20%)

$-0.11 (-2.52%)

148

Buy Since 20-Jul-2022

1 years 6 months 21 days ago
(02-Aug-2024)

0/1 (0%)

$12.65 (172.11%)

Buy Since 02-Dec-2020

$10

$5.66 (130.41%)

$10

2 years 6 months 1 days ago
(22-Aug-2023)

1/4 (25%)

$7.03 (236.70%)

28

Hold Since 14-Nov-2022

$7

$2.66 (61.29%)

3 years 2 months 15 days ago
(08-Dec-2022)

2/3 (66.67%)

$2.8 (66.67%)

79

Buy Since 01-May-2020

$26

3 years 3 months 9 days ago
(14-Nov-2022)

2/5 (40%)

$17.95 (222.98%)

182

Show more analysts

Please expand the browser size to see the chart

What is LUMO (Lumos Pharma) average time for price targets to be met?

On average it took 322.91 days on average for the stock forecasts to be realized with a an average price target met ratio 68.33

Which analyst has the current highest performing score on LUMO (Lumos Pharma) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on LUMO (Lumos Pharma)?

Peter Lawson works at BARCLAYS and has 7 price targets and 4 ratings on LUMO

Which analyst is the currently most bullish on LUMO (Lumos Pharma)?

Mara Goldstein with highest potential upside - $21.66

Which analyst is the currently most reserved on LUMO (Lumos Pharma)?

Michael Ulz with lowest potential downside - -$0.34

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?